You are here: Industry Insights > mRNA

News List

Urine test developed to diagnose subclinical kidney transplant rejection europeanpharmaceuticalreview
March 09, 2021
The novel, non-invasive test detects a rejection signature within mRNA isolated from urine and could, with further development, be used instead of biopsies to identify transplant rejection.
Cartesian Initiates Phase 2 Clinical Trial of RNA-Engineered Cell Therapy for Frontline Cancer americanpharmaceuticalreview
February 26, 2021
Cartesian Therapeutics has initiated a Phase 2a clinical trial of its mRNA chimeric antigen receptor (CAR) T-cell therapy, Descartes-11, in patients with newly diagnosed, high-risk multiple myeloma.
Evonik Announces Partnership with BioNTech for COVID-19 Vaccine americanpharmaceuticalreview
February 22, 2021
Evonik is investing in the short-term expansion of its specialty lipids production which are essential for mRNA-based COVID-19 vaccines.
Kaneka Eurogentec Expands Capabilities contractpharma
February 18, 2021
Kaneka Eurogentec, a custom service and FDA inspected contract development and manufacturing organization (CDMO), received GMP accreditation by the Belgian ministry of health for the GMP manufacturing of messenger RNA (mRNA).
Merck and BioNTech to boost lipid supply for Covid-19 vaccine production pharmaceutical-technology
February 09, 2021
Merck and BioNTech have announced a further expansion of their strategic partnership to accelerate the supply of urgently needed lipids and boost the amount of their delivery by the year-end.
CureVac & Rentschler Biopharma Collaborate on Vaccine contractpharma
February 09, 2021
CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), and Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for ...
BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong, S.A.R., China for COVID-19 Vaccine prnewswire
January 26, 2021
BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that according to the Food and Health Bureau of the Hong Kong, S.A.R., China Special Administrative Region of the PRC, the COVID-19 vaccine COMIRNATY® (also known as BNT162b2, Chine
ConserV Bioscience, LLNL to Collaborate on Development of Broad-spectrum Coronavirus Vaccine americanpharmaceuticalreview
January 25, 2021
ConserV Bioscience Limited and Lawrence Livermore National Laboratory (LLNL) have agreed to collaborate on the development of a broad-spectrum coronavirus vaccine.
ConserV Bioscience to develop ‘broad-spectrum’ coronavirus vaccine pharmatimes
January 21, 2021
UK biotech company ConserV Bioscience will collaborate on the development of a broad-spectrum coronavirus vaccine with Lawrence Livermore National Laboratory (LLNL).
MilliporeSigma Acquires AmpTec contractpharma
January 08, 2021
MilliporeSigma has announced the acquisition of AmpTec, a Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO).

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page